CoChat

Expression of Concern: Comparison of myo‐inositol and metformin on clinical, metabolic and genetic parameters in polycystic ovary syndrome: A randomized controlled clinical trial

Jamilian, Mehri, Farhat, Pegah, Foroozanfard, Fatemeh, Afshar Ebrahimi, Faraneh, Aghadavod, Esmat, Bahmani, Fereshteh, Badehnoosh, Bita, Jamilian, Hamidreza, Asemi, Zatollah · 2017 · Clinical Endocrinology
Cited by 31

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Summary: Objective: To our knowledge, data on comparison of myo‐inositol and metformin on clinical, metabolic and genetic parameters in subjects with polycystic ovary syndrome (PCOS) are limited. This study was carried out to compare myo‐inositol and metformin on clinical, metabolic and genetic parameters in subjects with PCOS. Design, patients and measurements: This randomized controlled trial was conducted among 60 subjects with PCOS aged 18‐40 years. Subjects were randomly allocated into two groups to receive either myo‐inositol (N=30) or metformin (N=30) for 12 weeks. Gene expression of inflammatory cytokines was assessed in peripheral blood mononuclear cells (PBMC s) of PCOS women by RT‐PCR. Results: After the 12‐week intervention, compared with metformin, myo‐inositol intake significantly decreased serum total testosterone (−1.4±4.2 vs +0.7±1.4 nmol/L, P=.03), modified Ferriman‐Gallwey (mF‐G) scores (−1.1±0.7 vs −0.5±0.8, P=.01) and serum high‐sensitivity C‐reactive protein (hs‐CRP) levels (−2.6±3.9 vs +0.2±1.5 mg/L, P<.001). RT‐PCR demonstrated that compared with metformin, myo‐inositol downregulated gene expression of interleukin‐1 (IL‐1) (P=.02) in PBMC s of subjects with PCOS. We did not observe any significant effect of myo‐inositol intake compared with metformin on other hormonal profiles, plasma nitric oxide (NO) or gene expression of IL‐8 and tumour necrosis factor alpha (TNF‐α). Conclusions: Overall, taking myo‐inositol, compared with metformin, for 12 weeks in patients with PCOS with hyperinsulinism and normoinsulinism had beneficial effects on total testosterone, mFG scores, serum hs‐CRP levels and gene expression of IL‐1, but did not affect other hormonal profiles, NO levels or gene expression of IL‐8 and TNF‐α.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/cen.13366

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 31

Metadata

Authors
Jamilian, M., Farhat, P., Foroozanfard, F., Afshar Ebrahimi, F., Aghadavod, E., Bahmani, F., Badehnoosh, B., Jamilian, H., & Asemi, Z.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2017-06-08
Volume
87
Issue
2
Pages
194-200
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2612952182
Cited by
31
References
9
FWCI
2.97
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Expression of Concern: Comparison of myo‐inositol and metformin on clinical, metabolic and genetic parameters in polycystic ovary syndrome: A randomized controlled clinical trial. https://app.cochat.ai/papers/10.1111/cen.13366
The paper
Jamilian, M., Farhat, P., Foroozanfard, F., Afshar Ebrahimi, F., Aghadavod, E., Bahmani, F., Badehnoosh, B., Jamilian, H., & Asemi, Z. (2017). Expression of Concern: Comparison of myo‐inositol and metformin on clinical, metabolic and genetic parameters in polycystic ovary syndrome: A randomized controlled clinical trial. Clinical Endocrinology. https://doi.org/10.1111/cen.13366

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.